Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income and comprehensive income	$ 177,170	$ 183,242
Adjustments to reconcile net income and comprehensive income to net cash provided by operating activities:
Depreciation, depletion and amortization	124,847	129,739
Non-cash employee stock compensation expense	7,342	6,632
Fair value changes in equity securities	171	1,221
Deferred tax benefit	(6,011)	(17,757)
Other	592	734
Changes in assets and liabilities:
Royalty receivables	14,678	25,612
Stream inventory	2,805	(2,083)
Income tax receivable	(11,182)	(10,141)
Prepaid expenses and other assets	(3,367)	(3,073)
Accounts payable	1,940	857
Income tax payable	6,428	2,646
Other liabilities	(709)	(1,310)
Net cash provided by operating activities	314,704	316,319
Cash flows from investing activities:
Acquisition of stream and royalty interests	(2,678)	(715,829)
Sale of equity securities	107
Other	(256)	(676)
Net cash used in investing activities	(2,827)	(716,505)
Cash flows from financing activities:
Repayment of debt	(250,000)	(50,000)
Borrowings from revolving credit facility		500,000
Debt issuance costs	(1,535)
Net payments from issuance of common stock	(1,373)	(1,438)
Common stock dividends	(73,918)	(68,938)
Other	(736)	(751)
Net cash (used in) provided by financing activities	(327,562)	378,873
Net decrease in cash and equivalents	(15,685)	(21,313)
Cash and equivalents at beginning of period	118,586	143,551
Cash and equivalents at end of period	$ 102,901	$ 122,238